Intriguingly, levels of ATF3, IL-22, and IL-22R were all upregulated in IBD patients (21, 26), suggesting that ATF3 could be associated with IL-22 signaling in gut inflamed tissues. Here, IL22 is linked to inflammatory bowel disease.